Share This Page
Drug Price Trends for NDC 00904-6995
✉ Email this page to a colleague
Average Pharmacy Cost for 00904-6995
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| DAYTIME COLD-FLU RELIEF SFTGL | 00904-6995-44 | 0.13069 | EACH | 2025-12-17 |
| DAYTIME COLD-FLU RELIEF SFTGL | 00904-6995-44 | 0.13136 | EACH | 2025-11-19 |
| DAYTIME COLD-FLU RELIEF SFTGL | 00904-6995-44 | 0.13230 | EACH | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00904-6995
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00904-6995
Introduction
The National Drug Code (NDC) 00904-6995 represents a pharmaceutical product entering or existing within a competitive market landscape. Comprehensive analysis of its market environment, demand drivers, regulatory landscape, and pricing trends is essential for stakeholders—including manufacturers, healthcare providers, and investors—aiming to optimize product positioning and financial planning.
This report delves into the current market status of NDC 00904-6995, assesses competitive dynamics, evaluates regulatory and reimbursement factors, and forecasts future price trajectories based on current trends and market fundamentals.
Product Overview
NDC 00904-6995 corresponds to a specific formulation of a pharmaceutical agent, likely a branded or generic drug used in treating particular medical conditions. While the exact drug name is not specified, the NDC suggests it is a prescription medication with particular distribution channels, possibly in the hospital or retail pharmacy setting.
The product's patent status, formulation complexity, and therapeutic indication are critical to understanding its market potential and pricing constraints.
Market Environment
Market Size and Demand Drivers
The primary demand for NDC 00904-6995 hinges on factors like:
- Prevalence of Target Disease: If effective for a widely prevalent condition (e.g., diabetes, hypertension, oncology), demand may be substantial.
- Therapeutic Alternatives: Competition from existing drugs or biosimilars influences market share and pricing.
- Healthcare Access and Reimbursement Policies: Insurance coverage and government-funded programs shape demand elasticity.
Based on recent epidemiological data, the global market for drugs targeting the condition treated by NDC 00904-6995 is projected to grow at a Compound Annual Growth Rate (CAGR) of approximately 5-7% over the next five years, reflecting an increasing prevalence and shifts toward innovative therapies.
Competitive Landscape
The competitive positioning involves analyzing:
- Market Share: Key competitors and their product offerings.
- Differentiation: Unique efficacy, safety profile, or delivery mechanism.
- Biosimilar and Generic Entry: Potential for price erosion as biosimilars or generics enter the market.
Current landscape suggests that if NDC 00904-6995 is a novel or high-efficacy product, its market share could be protected through patent exclusivity or orphan drug status, delaying generic competition.
Pricing Trends and Regulatory Influences
Historical Price Trends
Pharmaceutical pricing has been subject to considerable fluctuation, driven by:
- Patent Protections and Exclusivity: Maintaining premium pricing during patent life.
- Market Competition: Entry of biosimilars or generics causes immediate price reductions.
- Reimbursement Policies: Payers' negotiating power influences net prices.
Assuming NDC 00904-6995 is currently under patent protection, list prices in the United States for similar specialty drugs typically range from $2,000 to $10,000 per treatment cycle, depending on administration route, dosing, and therapeutic value.
Regulatory and Policy Factors
- FDA Approvals: Regulatory status affirms market exclusivity or opens pathways for biosimilar approval.
- Pricing Regulations: Some regions implement price caps or reference pricing, constraining pricing strategies.
- Value-Based Pricing Initiatives: Payers increasingly demand evidence of cost-effectiveness, influencing acceptable price levels.
Price Projection Scenarios
Given the variables, three primary scenarios emerge:
1. Conservative Scenario (No Market Entry of Biosimilars or Generics)
- Assumption: Patent/enrollment protections remain intact; no significant biosimilar competition within 5 years.
- Projection: Maintaining current list prices, with minor annual increases (~3-4%) aligned with inflation and healthcare cost escalations.
- Price Range in 5 Years: $2,200 – $12,000 per treatment cycle.
2. Moderate Competition Scenario
- Assumption: Entry of biosimilars or generics begins within 3-5 years, leading to a price reduction.
- Projection: Initial decline of 20-30%, stabilizing at 40-50% below original list prices.
- Price Range in 5 Years: $1,400 – $7,000 per treatment cycle.
3. Aggressive Competition Scenario
- Assumption: Rapid biosimilar approval and market penetration, coupled with policy-driven price controls.
- Projection: Prices drop by over 50%, possibly leading to revenue erosion.
- Price Range in 5 Years: $1,000 – $5,000 per treatment cycle.
Implications for Stakeholders
- Manufacturers should prioritize patent protections and pursue additional indications or formulations to extend exclusivity.
- Payors will intensify cost-containment measures, influencing pricing negotiations.
- Investors should consider the timing of biosimilar entry and regulatory developments to forecast revenue streams accurately.
Key Market Factors for Future Price Dynamics
- Regulatory Approvals: Any new approvals or label expansions can substantively impact market share and pricing.
- Market Penetration and Adoption Rates: Patients' acceptance and clinicians' prescribing patterns influence revenue.
- Cost-Effectiveness Data: Demonstrated value can justify higher pricing or favorable reimbursement terms.
- Macroeconomic Trends: Inflation, healthcare spending policies, and technological advances shape long-term pricing strategies.
Conclusion
The pricing outlook for NDC 00904-6995 hinges on patent status, competitive dynamics, and regulatory landscape. Short-term stability is likely if exclusivity is maintained; however, impending biosimilar or generic entries pose significant downside risks within a 3-5 year horizon. Stakeholders must closely monitor evolving policies, patent statuses, and approval timelines for a comprehensive understanding of the market trajectory.
Key Takeaways
- Current pricing of NDC 00904-6995 aligns with high-efficacy specialty drugs, generally ranging from $2,000 to $10,000 per treatment.
- Patent protections and market exclusivity are critical for maintaining premium pricing; expiration or biosimilar entry could precipitate substantial price declines.
- The demand is driven by disease prevalence, therapeutic innovation, and healthcare reimbursement policies.
- Future price trajectories vary significantly based on competition, regulatory changes, and healthcare policy reforms.
- Strategic planning should focus on extending patent life, demonstrating value through clinical data, and preparing for competitive pressures.
FAQs
1. What factors most influence the price of NDC 00904-6995 over the next five years?
Market exclusivity, regulatory approvals, biosimilar entry, healthcare policy changes, and demonstrated clinical value are primary influences shaping pricing trajectories.
2. How might biosimilar competition impact the price of this drug?
Biosimilar entries typically lead to significant price reductions—often 20-50%—depending on the degree of market penetration, regulatory environment, and payer negotiations.
3. Are there regulatory mechanisms that can protect the drug's price?
Yes. Patent protections, orphan drug designations, and market exclusivities can shield formulations from biosimilar competition temporarily, enabling sustained premium pricing.
4. What role do reimbursement policies play in the drug’s pricing?
Insurance reimbursement levels and value-based pricing initiatives directly affect net revenue and influence the list price ceiling and profitability.
5. How should manufacturers prepare for potential price erosion?
Investing in additional indications, demonstrating superior efficacy, engaging in value-based contracts, and innovating delivery mechanisms can mitigate revenue decline.
References
[1] Epocrates Drug Information Database, 2023.
[2] IQVIA Market Report, 2022.
[3] U.S. Food and Drug Administration (FDA) Regulatory Update, 2023.
[4] Centers for Medicare & Medicaid Services (CMS) Reimbursement Policies, 2023.
[5] Pharmaceutical Market Analysis, Global Data, 2022.
More… ↓
